243 related articles for article (PubMed ID: 9973954)
41. Comparison between interphase and metaphase cytogenetics in detecting chromosome 7 defects in hematological neoplasias.
Zhao L; van Oort J; Cork A; Liang JC
Am J Hematol; 1993 Jul; 43(3):205-11. PubMed ID: 8352237
[TBL] [Abstract][Full Text] [Related]
42. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
[TBL] [Abstract][Full Text] [Related]
43. Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes.
Kawankar N; Jijina F; Ghosh K; Vundinti BR
Cancer Epidemiol; 2011 Aug; 35(4):e1-5. PubMed ID: 21193364
[TBL] [Abstract][Full Text] [Related]
44. A unique clone involving multiple structural chromosome rearrangements in a myelodysplastic syndrome case.
Yan J; Whittom R; Delage R; Drouin R
Cancer Genet Cytogenet; 2003 Jan; 140(2):138-44. PubMed ID: 12645652
[TBL] [Abstract][Full Text] [Related]
45. [Detection of monosomy 7 or 7q- in cases of myelodysplastic syndrome].
Shen Y; Xue Y; Li J; Guo Y; Pan J; Wu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):255-8. PubMed ID: 11484160
[TBL] [Abstract][Full Text] [Related]
46. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
[TBL] [Abstract][Full Text] [Related]
47. Detection of monosomy 7 by fluorescence in situ hybridization in acute nonlymphocytic leukemia and myelodysplastic syndrome.
Nakagawa H
Jpn J Hum Genet; 1993 Sep; 38(3):257-66. PubMed ID: 8260718
[TBL] [Abstract][Full Text] [Related]
48. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
[TBL] [Abstract][Full Text] [Related]
49. [Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].
Gao DG; Li BT; Zhou LN; Chen H; Zhang B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1190-4. PubMed ID: 24156432
[TBL] [Abstract][Full Text] [Related]
50. Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.
Steensma DP; List AF
Mayo Clin Proc; 2005 May; 80(5):681-98. PubMed ID: 15887439
[TBL] [Abstract][Full Text] [Related]
51. Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?
Costa D; Valera S; Carrió A; Arias A; Muñoz C; Rozman M; Belkaid M; Coutinho R; Nomdedeu B; Campo E
Leuk Res; 2010 Nov; 34(11):1437-41. PubMed ID: 20226525
[TBL] [Abstract][Full Text] [Related]
52. Childhood myelodysplastic syndrome.
Chatterjee T; Choudhry VP
Indian J Pediatr; 2013 Sep; 80(9):764-71. PubMed ID: 23912822
[TBL] [Abstract][Full Text] [Related]
53. Der(5)t(5;7)(q11.2;p11.2): a new recurring abnormality in malignant myeloid disorders.
Thangavelu M; Bitter MA; Larson RA; Davis EM; Rowley JD; Le Beau MM
Cancer Genet Cytogenet; 1989 Jan; 37(1):1-8. PubMed ID: 2917326
[TBL] [Abstract][Full Text] [Related]
54. Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study.
Cherry AM; Brockman SR; Paternoster SF; Hicks GA; Neuberg D; Higgins RR; Bennett JM; Greenberg PL; Miller K; Tallman MS; Rowe J; Dewald GW
Leuk Res; 2003 Dec; 27(12):1085-90. PubMed ID: 12921944
[TBL] [Abstract][Full Text] [Related]
55. A novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome.
Lizcova L; Zemanova Z; Malinova E; Jarosova M; Mejstrikova E; Smisek P; Pospisilova D; Stary J; Michalova K
Cancer Genet Cytogenet; 2010 Aug; 201(1):52-6. PubMed ID: 20633770
[TBL] [Abstract][Full Text] [Related]
56. [Cytogenetics of myelodysplastic syndromes].
Laï JL; Fenaux P
Pathol Biol (Paris); 1997 Sep; 45(7):550-5. PubMed ID: 9404478
[TBL] [Abstract][Full Text] [Related]
57. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
58. [Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations in myelodysplastic syndromes].
Xiao B; Li JY; Pan JL; Ma L; Qiu HR; Wu YF; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):513-6. PubMed ID: 16468325
[TBL] [Abstract][Full Text] [Related]
59. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
Haferlach C; Bacher U; Tiu R; Maciejewski JP; List A
Cancer Genet Cytogenet; 2008 Dec; 187(2):101-11. PubMed ID: 19027491
[TBL] [Abstract][Full Text] [Related]
60. Spectral karyotyping study of chromosome abnormalities in human leukemia.
Zhao L; Hayes K; Khan Z; Glassman A
Cancer Genet Cytogenet; 2001 Jun; 127(2):143-7. PubMed ID: 11425454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
